These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2014712)

  • 41. Comparison of the efficacy and safety of daily dosages of 6 mg and 20 mg dihydroergocristine in the treatment of chronic cerebro-vascular disease.
    Pagliano FM; Galbiati GC
    J Int Med Res; 1995; 23(4):219-27. PubMed ID: 7589764
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oxiracetam in the treatment of multi-infarct dementia.
    Baumel B; Eisner L; Karukin M; MacNamara R; Katz RJ; Deveaugh-Geiss J
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(5):673-82. PubMed ID: 2781039
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antagonic-stress. A new treatment in gerontopsychiatry and for a healthy productive life.
    Predescu V; Riga D; Riga S; Turlea J; Bărbat IM; Botezat-Antonescu L
    Ann N Y Acad Sci; 1994 Jun; 717():315-31. PubMed ID: 8030848
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Responders and non-responders to bifemelane hydrochloride in Alzheimer-type and multi-infarct dementia.
    Shigeta M; Nishikawa Y; Shimizu M; Usui M; Hyoki K; Kawamuro Y
    Int Clin Psychopharmacol; 1993; 8(2):109-14. PubMed ID: 8345159
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Senile dementia: combined pharmacologic and psychologic treatment.
    Yesavage JA; Westphal J; Rush L
    J Am Geriatr Soc; 1981 Apr; 29(4):164-71. PubMed ID: 7204812
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The vertebral artery syndrome and patient management tactics].
    Panteleeva EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(12):46-50. PubMed ID: 23388592
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Electroencephalographic and clinical changes as correlated in geriatric patients treated three months with an ergot alkaloid preparation.
    Matejcek M; Knor K; Piguet PV; Weil C
    J Am Geriatr Soc; 1979 May; 27(5):198-202. PubMed ID: 372291
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Options for treatment for dementia patients.
    Walsh AC
    J Am Geriatr Soc; 1990 Jul; 38(7):829-30. PubMed ID: 2370404
    [No Abstract]   [Full Text] [Related]  

  • 49. Anticoagulant therapy for dementia.
    Walsh AC
    J Am Geriatr Soc; 1994 Feb; 42(2):227-8. PubMed ID: 8126343
    [No Abstract]   [Full Text] [Related]  

  • 50. Opportunities for and obstacles to treatments for dementias.
    Yesavage JA
    J Am Geriatr Soc; 1983 Jan; 31(1):59-60. PubMed ID: 6848578
    [No Abstract]   [Full Text] [Related]  

  • 51. Co-dergocrine.
    Krupp P; Loew DM
    Lancet; 1986 Dec; 2(8519):1335. PubMed ID: 2878201
    [No Abstract]   [Full Text] [Related]  

  • 52. Long-Term Nicergoline Treatment of Mild to Moderate Senile Dementia : Results of a Multicentre, Double-Blind, Placebo-Controlled Study.
    Nappi G; Bono G; Merlo P; Borromei A; Caltagirone C; Lomeo C; Martucci N; Fabbrini G; Annoni K; Battaglia A
    Clin Drug Investig; 1997 Jun; 13(6):308-16. PubMed ID: 27519492
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.
    Fioravanti M; Flicker L
    Cochrane Database Syst Rev; 2001; 2001(4):CD003159. PubMed ID: 11687175
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hydergine for dementia.
    Olin J; Schneider L; Novit A; Luczak S
    Cochrane Database Syst Rev; 2000; 2000(2):CD000359. PubMed ID: 10796534
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Therapy of organic brain syndrome with nicergoline given once a day].
    Ladurner G; Erhart P; Erhart C; Scheiber V
    Wien Klin Wochenschr; 1991; 103(1):8-14. PubMed ID: 2014712
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Therapy of multi-infarct dementia with nicergoline: double-blind, clinical, psychometric and EEG imaging studies with 2 dosage schedules].
    Saletu B; Hochmayer I; Grünberger J; Böhmer F; Paroubek J; Wicke L; Neuhold A
    Wien Med Wochenschr; 1987 Nov; 137(22):513-24. PubMed ID: 3324497
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A multicenter randomized double-blind study on the efficacy and safety of nicergoline in patients with multi-infarct dementia.
    Herrmann WM; Stephan K; Gaede K; Apeceche M
    Dement Geriatr Cogn Disord; 1997; 8(1):9-17. PubMed ID: 8997547
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nicergoline in senile dementia of Alzheimer type and multi-infarct dementia: a double-blind, placebo-controlled, clinical and EEG/ERP mapping study.
    Saletu B; Paulus E; Linzmayer L; Anderer P; Semlitsch HV; Grünberger J; Wicke L; Neuhold A; Podreka I
    Psychopharmacology (Berl); 1995 Feb; 117(4):385-95. PubMed ID: 7604138
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nicergoline in the treatment of dizziness in elderly patients. A review.
    Felisati G; Pignataro O; Di Girolamo A; Bruno E; Alessandrini M; Guidetti G; Monzani D; Beldi AM; Mira E; Benazzo M; Pallestrini E; Caligo G; Casani A; Battaglia A
    Arch Gerontol Geriatr Suppl; 2004; (9):163-70. PubMed ID: 15207410
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of intravenous high dose co-dergocrine mesylate ('Hydergine') in elderly patients with severe multi-infarct dementia: a double-blind, placebo-controlled trial.
    Arrigo A; Casale R; Giorgi I; Guarnaschelli C; Zelaschi F
    Curr Med Res Opin; 1989; 11(8):491-500. PubMed ID: 2680286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.